Covid-19 Brazil

Brazil approves Pfizer/BioNTech Covid-19 vaccine for children over 12

By Latin America News · June 11, 2021 · 1 min read

RIO DE JANEIRO, BRAZIL – (REUTERS) Brazil health regulator Anvisa on Friday said it had approved the use of the Pfizer/BioNtech Covid-19 vaccine for children over 12 years of age.

Anvisa said it approved the measure after seeing studies, conducted outside Brazil, that showed safety and efficacy for the age group.

One-stop reference

Company Intelligence

Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.

Browse the directory →

The vaccine, the first in Brazil to receive definitive approval from Anvisa, was already authorized for use on adolescents aged 16 and over, the regulator said. It added that the Pfizer vaccine was currently the only one authorized to be used on minors.

Brazil approves Pfizer/BioNTech Covid-19 vaccine for children over 12

Daily Brief

Related Articles

Jamaica Starts Talks With China, Cuba, and India for COVID Vaccines

Alarm over the number of Venezuelan military dead from COVID-19 without medical care or in temporary hospitals

RFK Jr. Confirmed as HHS Secretary: A New Era for U.S. Health Policy

CIA Backs Lab Leak Theory for COVID Origins, Fueling Global Distrust

Rotate for Best Experience

You've reached your free article limit